Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. - Wikidata - awgldk - TriplyDB

Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

http://www.wikidata.org/entity/Q38600691

about

Diabetic Cardiovascular Disease Induced by Oxidative Stress Nox family NADPH oxidases in mechano-transduction: mechanisms and consequences The role of oxidative stress and autophagy in atherosclerosis Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.Smooth muscle cells isolated from thoracic aortic aneurysms exhibit increased genomic damage, but similar tendency for apoptosis.Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection.Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms.A copy number variation in human NCF1 and its pseudogenes Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.The role of the renin-angiotensin system in aortic aneurysmal diseases.Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase.Cardiorenal syndrome caused by heart failure with preserved ejection fraction Nox2 is required for macrophage chemotaxis towards CSF-1.Animal models of cardiovascular diseases Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice Identification of Hic-5 as a novel scaffold for the MKK4/p54 JNK pathway in the development of abdominal aortic aneurysms.Role for Nox1 NADPH oxidase in atherosclerosis Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation.Reactive oxygen species in cardiovascular disease.Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm.Statin therapy reduces growth of abdominal aortic aneurysms.Cardiovascular biology of microsomal prostaglandin E synthase-1.p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice.Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo.Identification of key genes associated with the human abdominal aortic aneurysm based on the gene expression profile Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein E knockout mice.Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis.Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction.

P2860

Q26778017-8433560A-380E-42F2-B814-E3AA9582CAF8 Q26861569-6EFABD4E-EBB8-410C-851D-8CCFE4521448 Q28085161-2F378061-8C31-48AD-9FB3-DF7914995458 Q30277137-D6F7FF4E-1194-4B1E-8693-1A10346628D1 Q30433144-11F5C3E8-458C-4BF4-AF2C-6D98BECD28DB Q30525302-E0E1A55F-883D-44AA-BCDF-739C6C908538 Q30842247-349A3E42-D35A-41ED-9EC6-DC4D3914DF50 Q33290991-699BC111-ADB7-4CE9-AA43-7C9563673941 Q33533669-997B1C5C-38D5-43D0-A7FC-576FA71DF1BA Q33605449-3296652D-8011-48AA-9EE3-11CE347BE0C8 Q33757332-4C352E4E-59BA-4965-BAC7-F42E673DB466 Q33818137-C8CFE9AD-8021-42D4-88B7-E192ECFE4B1A Q33976385-D311253E-C06E-41C5-905A-061AC0F2161D Q34150874-FAFDE20B-0B4D-4150-AD59-5F50BB21E3B3 Q34217495-39138F9D-E541-44E7-AA24-C1E38AD57481 Q34571610-519ADB72-E6FC-475B-8A06-34FCFAA7B40F Q34577042-6F7A43A8-73C5-4FB0-9851-51F711EB9644 Q34591282-A3FBDA8D-FAB2-45F9-9EA7-91E99D8324E6 Q34627832-9985DC26-459E-41F8-B8B2-B69DAE84CF59 Q34674607-1DE064C5-07A9-4692-A982-F22BEBD17812 Q35021833-23AE9C9E-F81D-49CA-9E6F-4D58C3936AD3 Q35032392-5707F971-3F55-4C66-AEB8-13A68E22D19A Q35152116-7FC990E3-4DFE-48F0-B4C2-099671626A1B Q35159930-49174F3C-D2C5-4A67-906B-C0ADAEA5F204 Q35165194-107D59EE-DE63-424E-88C9-CF11ABCF86C1 Q35167994-B52958AA-4306-40DB-A959-FFF711E8DE46 Q35560673-3A762189-5875-44D7-A12F-FEF6613C9B58 Q35607129-FD674747-9E08-482C-94FE-369571FB522F Q35696706-B5143371-B6F4-4108-B23B-4C3CB77B343C Q35751030-D982F938-9799-468B-B41A-096AC8ACCC58 Q35925959-8D15E0EB-93AF-49FC-B95B-527401F01003 Q36144652-0D274FAB-E24F-4234-8E3F-C435865BBF28 Q36260295-F9A0F8BE-3542-4973-A529-AB4A1146BF46 Q36458652-EA4C501C-D898-47F0-8631-33921890BC7E Q36573893-7A63A57D-31B6-41C8-9501-B707F56F4F2F Q36592542-26FAF401-6203-43E9-BFB8-15BA160D4317 Q36999577-002B66CC-FB0C-4019-9FF7-D44090FB4397 Q37014137-5C6F60E5-9CAB-467B-98F8-0C422317E608 Q37139261-B739B48A-8FA7-4B24-B66C-A486A38730EB Q37161877-2C56B4E7-2A14-431B-A4B5-C1BA329B849A

P2860

Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

http://www.wikidata.org/entity/Q38600691

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Deletion of p47phox attenuates ...... olipoprotein E-deficient mice.

@en

type

label

Deletion of p47phox attenuates ...... olipoprotein E-deficient mice.

@en

prefLabel

Deletion of p47phox attenuates ...... olipoprotein E-deficient mice.

@en

P1433

Q38600691-CE87877D-592E-4862-A312-8B7018676440

P1476

Q38600691-ADD3D93C-FB61-4386-A916-2B41EFA47586

P2093

Q38600691-3EA3BF9B-60D7-4B8E-B4E2-7616207F18BE

Q38600691-525AB773-A47C-4E9C-8F79-7EF3FD2983F2

Q38600691-646FB9FA-2802-4E59-A90B-841FB451B369

Q38600691-655EF5E7-6F00-4D4D-8BF8-FFF46C983A1B

Q38600691-8983286F-30D6-419E-838D-E6FA9BB96096

Q38600691-97EDE4F9-C111-490F-B28A-14EB0838354F

Q38600691-A22D15A7-C5F1-4CBC-A8BB-90847CA19D84

Q38600691-D6116014-93BD-494C-915A-E91217ABD4A2

P2860

Q38600691-03B36BE6-83D1-4599-87E1-D81565DB4E9A

Q38600691-152F2DDB-0C63-42E2-A997-4EC8F9A0E29A

Q38600691-179AF3D8-81B7-4B18-8A12-9F85CF49ECC0

Q38600691-25E1C40B-1F12-4FC4-83AA-380F0C2148BC

Q38600691-283B0875-4042-4673-8A3E-FCECD7B74A58

Q38600691-54A968F1-2E3B-4F64-A758-16CAB0ED214B

Q38600691-5839F045-8498-4F47-BBED-CFAB6BF63378

Q38600691-609AA45E-1B5A-4DBA-8FD8-06CA869C28E4

Q38600691-6720224C-BB34-4FAD-BC26-43AAD65E5EA6

Q38600691-68B8713A-240D-4D2C-B4F0-3C0CEEBE5ECD

P304

Q38600691-54F0BD62-9CE5-4679-A9D8-FC4A8D6C0B0C

P31

Q38600691-3DCCE797-EB81-4958-8E69-BAC3DE5722CE

P356

Q38600691-DCDE6182-2CE9-4BCE-9AB9-5A49CE85B973

P407

Q38600691-ABAB541D-652E-4F11-A19C-1DFDC3AF5AEA

P433

Q38600691-639A4C6C-4FD4-4BBC-8235-79030CA86758

P478

Q38600691-E539C2BC-F32F-4371-8D84-389E4AA47490

P577

Q38600691-7D8E241D-F9DF-4AAE-95A1-68100C9AE78D

P698

Q38600691-5E368105-9678-44D2-942F-ACBB49BCF025

P932

Q38600691-414B7172-BC55-41FE-A0EA-65A89A4295AE

P356

CIRCULATIONAHA.105.607168

P1433

P1476

Deletion of p47phox attenuates ...... olipoprotein E-deficient mice.

@en

P2093

Alan Daugherty

http://www.w3.org/2001/XMLSchema#string

Dan Gavrila

http://www.w3.org/2001/XMLSchema#string

Francis J Miller

http://www.w3.org/2001/XMLSchema#string

Kevin C Dellsperger

http://www.w3.org/2001/XMLSchema#string

Lisa A Cassis

http://www.w3.org/2001/XMLSchema#string

Manesh Thomas

http://www.w3.org/2001/XMLSchema#string

Michael L McCormick

http://www.w3.org/2001/XMLSchema#string

Neal L Weintraub

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice

NAD(P)H oxidase: role in cardiovascular biology and disease

The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

Abdominal aortic aneurysms: basic mechanisms and clinical implications.

Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease.

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.

P304

404-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.105.607168

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16864727

http://www.w3.org/2001/XMLSchema#string

P932

3974117

http://www.w3.org/2001/XMLSchema#string